. 2017 Sep 30;6(2):66–70. doi: 10.1016/j.prnil.2017.09.003

Table 1.

Patient characteristics

Variable	Value (n = 63)
Age [y], median (range)	62 (49–73)
Prostate volume [mL], median (range)	40 (22–64)^a)
PSA [μg/L], median (range)	6.61 (0.07–54.0)^b)
PCa stage T1c/T2a/T2b/T2c	42/16/4/1
Gleason score 4/5/6/7	2/5/52/2^c)

PCa, prostate cancer; PSA, prostate specific antigen.

^a)

Downsizing of prostate volume with androgen deprivation therapy (ADT) in seven patients.

^b)

Including PSA values after downsizing of prostate volume with ADT.

^c)

Gleason score in two patients not definable because of insufficient tissue.